Value proposition

SurgicEye is developing and providing innovative solutions to expand the use of nuclear medicine images. With the declipseSPECT Suite, SurgicEye enables increased application specific imaging, hybrid imaging by ultrasound SPECT fusion, interventional nuclear medicine, and intraoperative SPECT imaging and soft tissue guidance. Application domains focus on improved diagnostics for thyroid cancer, parathyroid detection, sentinel lymph node mapping and biopsy, as well as other radio-guided surgery solutions.

Nuclear Medicine, Interventional Imaging, Radio-guided Surgery, Image Guided Surgery, SPECT Augmented Ultrasound Imaging, and Hybrid Imagind